Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Holliger

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Structure (London, England : 1993)|February 15, 1997
A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fdP Holliger, L Riechmann
Current Opinion in Biotechnology|August 1, 1993
Engineering bispecific antibodiesP Holliger, G Winter
Methods in Enzymology|October 19, 2000
Methods for generating multivalent and bispecific antibody fragmentsI Tomlinson, P Holliger
Cancer Metastasis Reviews|June 16, 2000
Engineering antibodies for the clinicP Holliger, H Bohlen
Nature Biotechnology|November 27, 1998
Antibodies come back from the brinkP Holliger, H Hoogenboom
Cell|July 25, 1997
The C-terminal domain of TolA is the coreceptor for filamentous phage infection of E. coliL Riechmann, P Holliger
Nature Biotechnology|July 1, 1997
Antibodies live long and prosperL Riechmann, P Holliger
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Diabodies: small bispecific antibody fragmentsP Holliger, G Winter
Trends in Biotechnology|January 1, 1995
Artificial antibodies and enzymes: mimicking nature and beyondP Holliger, H R Hoogenboom
Protein Engineering|March 6, 1998
Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastorisK FitzGerald, P Holliger, G Winter
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Structure (London, England : 1993)|February 15, 1997
A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fdP Holliger, L Riechmann
Current Opinion in Biotechnology|August 1, 1993
Engineering bispecific antibodiesP Holliger, G Winter
Methods in Enzymology|October 19, 2000
Methods for generating multivalent and bispecific antibody fragmentsI Tomlinson, P Holliger
Cancer Metastasis Reviews|June 16, 2000
Engineering antibodies for the clinicP Holliger, H Bohlen
Nature Biotechnology|November 27, 1998
Antibodies come back from the brinkP Holliger, H Hoogenboom
Cell|July 25, 1997
The C-terminal domain of TolA is the coreceptor for filamentous phage infection of E. coliL Riechmann, P Holliger
Nature Biotechnology|July 1, 1997
Antibodies live long and prosperL Riechmann, P Holliger
Cancer Immunology, Immunotherapy : CII|January 22, 1998
Diabodies: small bispecific antibody fragmentsP Holliger, G Winter
Trends in Biotechnology|January 1, 1995
Artificial antibodies and enzymes: mimicking nature and beyondP Holliger, H R Hoogenboom
Protein Engineering|March 6, 1998
Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastorisK FitzGerald, P Holliger, G Winter
Pageof 3